Eligibility criteria in venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users

Obstetrics and Gynecology

Volumn 114, Issue 1, 2009, Pages 175-

  Dore, David D ^a   Norman, Heather ^a   Seeger, John D ^a  

^a i3 Drug Safety   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ETHINYLESTRADIOL PLUS NORGESTIMATE;

DATA ANALYSIS; DATA SYNTHESIS; HEART INFARCTION; HUMAN; LETTER; METHODOLOGY; PRIORITY JOURNAL; SAMPLE SIZE; SKIN CANCER; STROKE; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, CUTANEOUS; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; MYOCARDIAL INFARCTION; STROKE; VENOUS THROMBOEMBOLISM;

EID: 67651071546     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181aa92ee     Document Type: Letter

References (2)

1. Cole JA, Norman H, Doherty M, Walker AM. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users [published erratum appears in Obstet Gynecol 2008;111:1449]. Obstet Gynecol 2007;109:339-46.
2. Schneeweiss S, Patrick AR, Sturmer T, Brookhart MA, AvornJ, Maclure M, et al. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care 2007; 45:S131-42.